Navigation Links
Extended Antiviral May Benefit Kidney Transplant Patients
Date:9/17/2009

Risk of viral infection can be cut in half with 6 months of treatment, study finds

THURSDAY, Sept. 17 (HealthDay News) -- A longer period of preventive treatment after kidney transplant can help reduce the risk that the patient will become infected with a virus that can cause devastating problems, new research suggests.

Healthy people can usually fight off the virus, called cytomegalovirus, but those with kidney transplants have weakened immune systems and are more susceptible to infection, the authors of the study noted in a news release from the American Society of Nephrology.

In the comparison study, Dr. Fu Luan, of the University of Michigan in Ann Arbor, and colleagues gave kidney transplant patients either three months or six months of treatment with the antiviral drug valganciclovir. They found that those who were given the longer treatment had a rate of infection that was half that of those who received treatment for three months (12 percent vs. 24 percent).

When the researchers took into account other factors that could have played a role, they found that the longer treatment regimen lowered the risk of cytomegalovirus by nearly two-thirds.

The study also found that the longer treatment is cost-effective, although it is expensive. But the study authors contend that it's cheaper in the long run to prevent infections that could end up being very costly.

The findings appear online Sept. 17 in the Journal of the American Society of Nephrology.

More information

Learn more about kidney transplants from the U.S. National Library of Medicine.



-- Randy Dotinga



SOURCE: American Society of Nephrology, news release, Sept. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
2. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
3. Deadline Extended for Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award
4. Shires INTUNIV (Guanfacine) extended release in children with ADHD and oppositional symptoms
5. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
6. New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
7. Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
8. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
9. Cipher receives tentative FDA approval for extended-release tramadol capsules
10. Bioniche Warrants Expiration Date to be Extended
11. Teaching Hospitals Post-Op Gains Not Extended to Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Extended Antiviral May Benefit Kidney Transplant Patients
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce ... ever created for kids with cancer. The Chemo Duck App, available ... filled with enjoyable games to help children of all ages living ... helps to keep kids entertained, educated and at ease while waiting ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Angelweddingdress is a ... business invites its customers to follow it on Facebook, Twitter, ... a Valentine’s Day gift. Angelweddingdress draws a lottery every week. ... Sale to Feb. 28, 2015. Click Angelweddingdress homepage ...
(Date:1/22/2015)... the premier women’s dress supplier, has recently released its ... of AngelWeddingDress.com to find more details. , Many ... a bridal party. AngelWeddingDress offers a variety of gorgeous ... wedding dresses are specially designed for 2015. , AngelWeddingDress ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... to consider the rising health emergencies and crisis in ... have helped// to promote closer regional cooperation. ... attempts for development of sustainable programs for Southeast Asian ... the 8th ASEAN Health Ministers Meeting was the ...
... use a protein that has been originally isolated from fish ... modified technology. ,The parent company, Unilever, have claimed ... creams that are of low-calorie, and low fat. They explained ... versions of their best selling products like the Cornetto, Magnum, ...
... is because hospitals in England are so overcrowded, says a ... study found that more than three-quarters of hospitals in the ... occupancy rates with a third of the trusts exceeding 81 ... that the high rates mean that there is very less ...
... Bibi in Pakistan's North West Frontier Province (NWFP) had never ... to look for buyers. ,It was the only ... husband Izat Gul, 43 - could think of to raise ... ,They struck a deal with a family they ...
... In a bid to upgrade tertiary healthcare infrastructure and ... institutions in the country// at a cost of Rs.15.6 ... taken at a meeting of the Cabinet Committee on ... an eye on underserved states like Jammu and Kashmir, ...
... US has teamed up with the UN's Children's Fund to ... in seven provinces of China. ,Dubbed as 'Skills ... learning materials for teachers and peer educators to use in ... and other sports equipment to help young people learn about ...
Cached Medicine News:Health News:Regional Cooperation Promoted in Southeast Asia 2Health News:Wall's To Develop Low-fat Ice-cream Using Fish Blood 2Health News:Impoverished Parents sell their Daughter to Treat their Ailing Kids 2
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... and development company, is delighted to announce that the ... to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for the ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... at the American Heart Association Scientific Sessions ... ... Nabi,Biopharmaceuticals (Nasdaq: NABI ) today announced the successful ... the,company,s innovative and proprietary investigational vaccine being,developed to treat nicotine ...
... announced,today that the first patient was enrolled in ... the treatment of herpes zoster, also known as,shingles. ... and bioavailability. "The initiation of this dose-finding ... valomaciclovir," said Fred Volinsky, MD, Chief Executive,Officer. "Shingles, ...
Cached Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: